Diagnostic and Prognostic Value of Plasma Adrenomedullin in COPD Exacerbation

Abstract

Plasma ADM is a valuable biomarker to confirm COPD exacerbation; furthermore, plasma ADM independently predicts the need of ICU care, although it is not associated with long-term mortality in patients with COPD exacerbation.